Cytos amends rights offering

Cytos Biotechnology AG (SIX:CYTN), Schlieren, Switzerland Business: Neurology, Inflammation, Infectious Date announced: 11/5/13 Type: Rights offering To be raised: Up to CHF17.6 million ($19.3 million...